BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 34090477)

  • 61. Different mechanisms of inflammation induced in virus and autoimmune-mediated models of multiple sclerosis in C57BL6 mice.
    Kishore A; Kanaujia A; Nag S; Rostami AM; Kenyon LC; Shindler KS; Das Sarma J
    Biomed Res Int; 2013; 2013():589048. PubMed ID: 24083230
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.
    Chechneva OV; Mayrhofer F; Daugherty DJ; Pleasure DE; Hong JS; Deng W
    Neurobiol Dis; 2011 Oct; 44(1):63-72. PubMed ID: 21704706
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis.
    Bando Y; Hagiwara Y; Suzuki Y; Yoshida K; Aburakawa Y; Kimura T; Murakami C; Ono M; Tanaka T; Jiang YP; Mitrovi B; Bochimoto H; Yahara O; Yoshida S
    Glia; 2018 Feb; 66(2):359-378. PubMed ID: 29086442
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistochemical analysis of spinal cord components in mouse model of experimental autoimmune encephalomyelitis.
    Pyka-Fosciak G; Stasiolek M; Litwin JA
    Folia Histochem Cytobiol; 2018; 56(3):151-158. PubMed ID: 30187907
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
    Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M
    J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis.
    Han J; Zhu K; Zhou K; Hakim R; Sankavaram SR; Blomgren K; Lund H; Zhang XM; Harris RA
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957621
    [TBL] [Abstract][Full Text] [Related]  

  • 67. EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE).
    Munro KM; Dixon KJ; Gresle MM; Jonas A; Kemper D; Doherty W; Fabri LJ; Owczarek CM; Pearse M; Boyd AW; Kilpatrick TJ; Butzkueven H; Turnley AM
    PLoS One; 2013; 8(2):e55948. PubMed ID: 23390555
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
    Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
    J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
    [TBL] [Abstract][Full Text] [Related]  

  • 69. NG2 positive cells of rat spinal cord activated during experimental autoimmune encephalomyelitis are spatially associated with radially oriented astroglia and express p75 receptor: a role for nerve growth factor in oligodendrocyte progenitor migration?
    Oderfeld-Nowak B; Zaremba M; Kwiatkowska-Patzer B; Lipkowski AW; Kurkowska-Jastrzebska I; Triaca V; Aloe L
    Arch Ital Biol; 2009 Dec; 147(4):105-15. PubMed ID: 20162860
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
    Yin LL; Lin LL; Zhang L; Li L
    Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A new mouse model to study restoration of interleukin-6 (IL-6) expression in a Cre-dependent manner: microglial IL-6 regulation of experimental autoimmune encephalomyelitis.
    Sanchis P; Fernández-Gayol O; Comes G; Aguilar K; Escrig A; Giralt M; Palmiter RD; Hidalgo J
    J Neuroinflammation; 2020 Oct; 17(1):304. PubMed ID: 33059703
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nogo receptor expression in microglia/macrophages during experimental autoimmune encephalomyelitis progression.
    Alrehaili AA; Lee JY; Bakhuraysah MM; Kim MJ; Aui PM; Magee KA; Petratos S
    Neural Regen Res; 2018 May; 13(5):896-907. PubMed ID: 29863021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis.
    Marusic S; Leach MW; Pelker JW; Azoitei ML; Uozumi N; Cui J; Shen MW; DeClercq CM; Miyashiro JS; Carito BA; Thakker P; Simmons DL; Leonard JP; Shimizu T; Clark JD
    J Exp Med; 2005 Sep; 202(6):841-51. PubMed ID: 16172261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Changes in spinal cord stiffness in the course of experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.
    Pyka-Fościak G; Zemła J; Lis GJ; Litwin JA; Lekka M
    Arch Biochem Biophys; 2020 Feb; 680():108221. PubMed ID: 31816310
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Centrally administered pertussis toxin inhibits microglia migration to the spinal cord and prevents dissemination of disease in an EAE mouse model.
    Yin JX; Tu JL; Lin HJ; Shi FD; Liu RL; Zhao CB; Coons SW; Kuniyoshi S; Shi J
    PLoS One; 2010 Aug; 5(8):e12400. PubMed ID: 20811645
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis.
    Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M
    Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
    Smith BC; Sinyuk M; Jenkins JE; Psenicka MW; Williams JL
    J Neuroinflammation; 2020 Jun; 17(1):184. PubMed ID: 32532298
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Novel disease-modifying anti-rheumatic drug iguratimod suppresses chronic experimental autoimmune encephalomyelitis by down-regulating activation of macrophages/microglia through an NF-κB pathway.
    Li G; Yamasaki R; Fang M; Masaki K; Ochi H; Matsushita T; Kira JI
    Sci Rep; 2018 Jan; 8(1):1933. PubMed ID: 29386552
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gray Matter Hypoxia in the Brain of the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
    Johnson TW; Wu Y; Nathoo N; Rogers JA; Wee Yong V; Dunn JF
    PLoS One; 2016; 11(12):e0167196. PubMed ID: 27907119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.